CN102114024B - 预防月经期偏头痛的复方雌谷胶囊 - Google Patents

预防月经期偏头痛的复方雌谷胶囊 Download PDF

Info

Publication number
CN102114024B
CN102114024B CN2009102561353A CN200910256135A CN102114024B CN 102114024 B CN102114024 B CN 102114024B CN 2009102561353 A CN2009102561353 A CN 2009102561353A CN 200910256135 A CN200910256135 A CN 200910256135A CN 102114024 B CN102114024 B CN 102114024B
Authority
CN
China
Prior art keywords
capsules
menstrual period
migraine
vitamin
cigu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2009102561353A
Other languages
English (en)
Other versions
CN102114024A (zh
Inventor
宋杰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2009102561353A priority Critical patent/CN102114024B/zh
Publication of CN102114024A publication Critical patent/CN102114024A/zh
Application granted granted Critical
Publication of CN102114024B publication Critical patent/CN102114024B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

本发明属于医药技术领域,公开了一种预防月经期偏头痛的复方雌谷胶囊,它是以尼尔雌醇、谷维素、维生素B1、维生素B2为原料,根据每种药物原料不同特征,分别按比例配置,经低温干燥、研细、调匀、灭菌等处理,制成一种胶囊。本发明具有可有效补充月经期间骤降的雌二醇,缓解患者的焦虑、紧张情绪,减少月经性偏头痛的发作次数,减轻月经性偏头痛的发作程度,提高了患者的生活质量等优点,且配方新、药物配置原料来源广泛、廉价、制作方便、药品成本低,无不良反应,患者易接受。经临床150例月经性偏头痛患者使用,总有效率达96%,未见特殊毒副作用。

Description

预防月经期偏头痛的复方雌谷胶囊
技术领域
本发明属药品,具体讲是一种预防月经期偏头痛的复方雌谷胶囊。
背景技术
月经期偏头痛是一种与卵巢周期变化有关的特殊类型的偏头痛,占女性偏头痛的60%以上,常常发生在月经前1~7天、月经期或月经后1~2天,经期头痛加重,每月发作1次或1次以上,往往有家族遗传史。研究发现,偏头痛的发作与月经前雌二醇的骤降有密切关系,而与黄体酮下降无明显关系。近几年注意到精神状态、紧张和疲劳等是偏头痛发作的诱发因素。临床上多采用镇痛、止吐、麦角胺类药物治疗。麦角胺类是5-羟色胺(5-HT)受体的促动剂,主要激动5-HTIA受体,但对多巴胺、肾上腺素受体也有作用,其过量会出现恶心、呕吐、腹痛、肌痛及周围血管痉挛、缺血等不良作用。近年5-HTIA/ID激动药曲普坦、左米曲坦治疗偏头痛有新突破,但药源受限制,且价格偏高,不能广泛应用于临床。
发明内容
本发明的目的在于提供一种预防月经期偏头痛的有效率高、副作用小、费用低的复方雌谷胶囊。
本发明的目的是通过以下方式实现的:一种预防月经期偏头痛的复方雌谷胶囊,该复方雌谷胶囊是由尼尔雌醇、谷维素、维生素B1、维生素B2四种西药成份组成,其特征在于复方雌谷胶囊中各种药物重量百分比分别为:尼尔雌醇2%-3%、谷维素50%-52%、维生素B120%-22%、维生素B224%-26%。根据月经期偏头痛发病机制,尼尔雌醇为雌三醇衍生物,为长效雌激素,有较强的雌激素作用,其口服雌激素活性为炔雌醚的3倍,作用维持时间较长。谷维素主要存在于毛糠油及其油脚中,其主要功能为抗氧化、抗衰老,可改善植物神经功能失调、内分泌平衡障碍及精神神经失调。同时能稳定情绪、减轻焦虑及紧张状态,并改善睡眠。维生素B2促进细胞内氧化-还原反应,维持线粒体的正常功能。维生素B1在维持神经系统的正常功能中起重要作用。该复方雌谷胶囊经临床150例月经性偏头痛患者试验,可有效补充月经期间骤降的雌二醇,缓解患者的焦虑、紧张情绪,减少月经性偏头痛的发作次数,减轻月经性偏头痛的发作程度,提高了患者的生活质量。且配方新、药物配置原料来源广泛、廉价、制作方便、药品成本低,无不良反应,患者易接受。
预防月经期偏头痛的复方雌谷胶囊的配制方法如下:分别将尼尔雌醇2%-3%、谷维素50%-52%、维生素B120%-22%、维生素B224%-26%按比例配置,经低温干燥、研细、调匀、灭菌等处理,分装胶囊,每粒胶囊含药粉0.1g,按每瓶30粒胶囊装瓶,封口,贴签。于月经前9~10天口服,每次2粒,每日1次,月经结束后停服。治疗3个月为一疗程。
本复方雌谷胶囊适用于月经期偏头痛患者。治疗期间应避免过度劳累,用药后30分钟内不得服用其他药物。
实施例:将500mg尼尔雌醇、10300mg谷维素、4200mg维生素B1、5000mg维生素B2经低温干燥、研细、调匀、灭菌等处理,分装胶囊,每粒胶囊含药粉0.1g,按每瓶30粒胶囊装瓶,封口,贴签。

Claims (1)

1.预防月经期偏头痛的复方雌谷胶囊,其特征是由尼尔雌醇、谷维素、维生素B1、维生素B2四种西药成份组成,各种药物重量百分比分别为:尼尔雌醇2%-3%、谷维素50%-52%、维生素B120%-22%、维生素B224%-26%。
CN2009102561353A 2009-12-30 2009-12-30 预防月经期偏头痛的复方雌谷胶囊 Expired - Fee Related CN102114024B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009102561353A CN102114024B (zh) 2009-12-30 2009-12-30 预防月经期偏头痛的复方雌谷胶囊

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009102561353A CN102114024B (zh) 2009-12-30 2009-12-30 预防月经期偏头痛的复方雌谷胶囊

Publications (2)

Publication Number Publication Date
CN102114024A CN102114024A (zh) 2011-07-06
CN102114024B true CN102114024B (zh) 2012-05-30

Family

ID=44213024

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009102561353A Expired - Fee Related CN102114024B (zh) 2009-12-30 2009-12-30 预防月经期偏头痛的复方雌谷胶囊

Country Status (1)

Country Link
CN (1) CN102114024B (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102114024B (zh) * 2009-12-30 2012-05-30 宋杰 预防月经期偏头痛的复方雌谷胶囊

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1079396A (zh) * 1992-12-20 1993-12-15 淄博市淄川区第二制药厂 增智药物制剂增智素
IE61350B1 (en) * 1986-08-04 1994-11-02 Univ Florida Method for treating male sexual dysfunction
CN1199614A (zh) * 1997-05-20 1998-11-25 黄茹 中老年妇女保健药
CN1257707A (zh) * 1999-05-31 2000-06-28 宋晓恩 一种改善老年人生命活力的保健药及配方
CN102114024A (zh) * 2009-12-30 2011-07-06 宋杰 预防月经期偏头痛的复方雌谷胶囊

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE61350B1 (en) * 1986-08-04 1994-11-02 Univ Florida Method for treating male sexual dysfunction
CN1079396A (zh) * 1992-12-20 1993-12-15 淄博市淄川区第二制药厂 增智药物制剂增智素
CN1199614A (zh) * 1997-05-20 1998-11-25 黄茹 中老年妇女保健药
CN1257707A (zh) * 1999-05-31 2000-06-28 宋晓恩 一种改善老年人生命活力的保健药及配方
CN102114024A (zh) * 2009-12-30 2011-07-06 宋杰 预防月经期偏头痛的复方雌谷胶囊

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
孟琳等.尼尔雌醇治疗流动育龄妇女继发性闭经39例体会.《齐齐哈尔医学院学报》.2007,(第10期),1203-1204. *
郭述苏等.月经期与偏头痛相关的研究.《中国疼痛医学杂志》.1995,(第01期),7-10. *
饶志青等.激素替代疗法治疗围绝经期妇女灼口征的体会.《遵义医学院学报》.2003,第26卷(第05期),466-467. *

Also Published As

Publication number Publication date
CN102114024A (zh) 2011-07-06

Similar Documents

Publication Publication Date Title
Vijayakumar et al. Drug-induced dyskinesia, part 1: treatment of levodopa-induced dyskinesia
Vijayakumar et al. Drug-induced dyskinesia, part 2: treatment of tardive dyskinesia
Vaswani et al. Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review
AU2024203369A1 (en) Methods and compositions for enhancing health
Gonzalez-Latapi et al. Non-dopaminergic treatments for motor control in Parkinson’s disease: an update
WO2016145910A1 (zh) Nadh和nmn在制备帕金森病药物或保健品的应用
Rindone et al. Warfarin-cranberry juice interaction resulting in profound hypoprothrombinemia and bleeding
JP2012236834A5 (zh)
JP2005525329A (ja) 向精神薬とセレンから成る配合物
Powers et al. Pharmacotherapy for eating disorders and obesity
CN102198108B (zh) 一种盐酸西那卡塞片剂或胶囊制备工艺
CN102114024B (zh) 预防月经期偏头痛的复方雌谷胶囊
CN101306011B (zh) 一种用于综合降血压的功能食品
CN106667903A (zh) 一种治疗白癜风的氟西汀酊剂
Seamon et al. Ephedra: yesterday, DSHEA, and tomorrow—a ten year perspective on the Dietary Supplement Health and Education Act of 1994
JP2018138582A (ja) キトオリゴ糖を含有するアミラーゼ活性阻害用組成物
Peralta Depression: It Matters!
US20150273007A1 (en) Blood pressure reduction with dietary supplements
JP2009196972A (ja) 医薬組成物
Dickerson et al. Pharmacotherapy for the obese patient
Ajagun-Ogunleye et al. Hypoglycemic and high dosage effects of bidens pilosa in type-1 diabetes mellitus
NL2005194C2 (en) Pharmaceutical composition for use in the prevention and treatment of gingivitis and parodontitis.
RU2530628C1 (ru) Фармацевтическая композиция и набор для лечения и/или предупреждения нарушений, связанных с ожирением, и способ лечения и/или предупреждения нарушений, связанных с ожирением
JP2007137896A (ja) イブプロフェン含有医薬製剤
Chen et al. Mitigation of high-fat diet-induced sarcopenia by Toona sinensis fruit extracts via autophagic flux and mitochondrial quality control

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120530

Termination date: 20121230